	US 12,138,287 B2
	Use of Antrodia cinnamomea for increasing alcohol metabolism or/and hangover
Pang-Kuei Hsu, Taichung (TW); and Chia-Feng Wu, Taichung (TW)
Assigned to GREENYN BIOTECHNOLOGY CO., LTD, Taichung (TW)
Filed by Greenyn Biotechnology Co., Ltd, Taichung (TW)
Filed on Jul. 24, 2023, as Appl. No. 18/357,668.
Application 18/357,668 is a division of application No. 17/203,145, filed on Mar. 16, 2021, granted, now 11,759,488.
Claims priority of application No. 109108997 (TW), filed on Mar. 18, 2020.
Prior Publication US 2023/0364169 A1, Nov. 16, 2023
Int. Cl. A61K 36/00 (2006.01); A61K 9/00 (2006.01); A61K 36/07 (2006.01); A61P 25/32 (2006.01)

CPC A61K 36/07 (2013.01) [A61K 9/0053 (2013.01); A61P 25/32 (2018.01)]

1 Claim

1. A method for treating or preventing acute alcoholism or liver disease caused by an elevated plasma alcohol level in a subject, comprising administering an effective amount of Antrodia cinnamomea powder or a composition thereof to the subject who has an elevated plasma alcohol level, whereby the administration of Antrodia cinnamomea powder or the composition thereof for increasing alcohol dehydrogenase, acetaldehyde dehydrogenase or SOD enzyme activity, wherein the effective amount of the Antrodia cinnamomea powder is at least 79.5 mg/day for an adult.